ReferIndia News 'Health Risk': Novo Nordisk Sues Hims & Hers Over Cheaper Version Of Ozempic, Wegovy Fat Loss Pills

ReferIndia News

✅ Secure, cloud-based clinic management.

Digital prescriptions, appointments, billing & records — all in one.

Learn More
News Image

'Health Risk': Novo Nordisk Sues Hims & Hers Over Cheaper Version Of Ozempic, Wegovy Fat Loss Pills

Published on: Feb. 9, 2026, 7:31 p.m. | Source: NDTV Profit

Hims had planned to sell the drug at a sharply discounted price of $49 for the first month, which is almost $100 less than Novo's approved Wegovy pill.

Checkout more news
Ad Banner

Looking for free cloud deployment?

Sign up & get $200 free credit for 60 days to launch your first Droplet or GPU server on DigitalOcean 🚀

Signup Now
ReferIndia News contact